Key result
Global thalassemia-related HF burden continues to rise, peaking at ~1.6 per 100,000 in Pakistan.
Why the study?
The study was conducted to assess the prevalence trend and contributing factors of heart failure impairment with thalassemias at global, regional, and national levels.
Observational
Yes
Effect estimate: EAPC -0.98
The global burden of heart failure related to thalassemias is increasing, with significant disparities across regions and a growing gender gap.
Supports heightened surveillance in high-burden regions; leaves open longitudinal studies to guide interventions.
BACKGROUND: To assess the prevalence trend and contributing factors of heart failure (HF) impairment with thalassemias at global, regional and national levels. METHODS: Data on HF impairment with thalassemias was collected from the Global Burden of Disease study. The absolute number and prevalence of the disease were systematically collected for each year, and the estimated annual percentage changes (EAPC) in HF impairment were calculated by gender, region and country to measure temporal trends. RESULTS: Thalassemias have caused a significant global burden since 1990, and the case number of HF related to thalassemias has been steadily increasing. The highest case number of HF impairments with thalassemias is observed in China (7739 cases) and the highest prevalence is in Pakistan (1.61 per 100,000) currently. Besides, the middle sociodemographic index (SDI) region carries the highest burden of comorbid disease yet exhibits the most evident trend for improvement across the five regions (EAPC = -.98). The burden of thalassemias and comorbid HF is generally higher in males than females with the gender gap growing chasm in the future. Besides, the hotspots of HF impairment with thalassemias have gradually shifted to low SDI regions, though middle SDI regions still hold a relatively higher prevalence (.37 per 100,000) across different regions. CONCLUSIONS: The burden of thalassemias and accompanying HF, as well as their temporal trends, vary greatly across countries and regions. These findings can improve understanding of these conditions and guide policymakers in developing appropriate policies to address disparities between countries.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2023) conducted an observational in Heart failure impairment with thalassemias. Thalassemias was evaluated on Prevalence and estimated annual percentage changes (EAPC) in heart failure impairment (EAPC -0.98). The global burden of heart failure related to thalassemias has steadily increased since 1990, with the highest current prevalence in Pakistan (1.61 per 100,000) and highest case number in China.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: